John Öhd
Modus Therapeutics (Sweden)(SE)
Publications by Year
Research Areas
Inflammatory mediators and NSAID effects, Estrogen and related hormone effects, Cytokine Signaling Pathways and Interactions, Helicobacter pylori-related gastroenterology studies, Asthma and respiratory diseases
Most-Cited Works
- → Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas(2003)193 cited
- → Disease-Modifying Effects of a Novel Cathepsin K Inhibitor in Osteoarthritis(2019)138 cited
- → Leukotrienes induce cell-survival signaling in intestinal epithelial cells(2000)114 cited
- → A Novel Localization of the G-Protein-Coupled CysLT1 Receptor in the Nucleus of Colorectal Adenocarcinoma Cells(2005)110 cited
- → Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study(2006)76 cited
- → The Inflammatory Mediator Leukotriene D4 Induces β-Catenin Signaling and Its Association with Antiapoptotic Bcl-2 in Intestinal Epithelial Cells(2006)61 cited
- → Worse survival for TP53 (p53)-mutated breast cancer patients receiving adjuvant CMF(2005)57 cited
- → Activated ERK1/2 and phosphorylated oestrogen receptor α are associated with improved breast cancer survival in women treated with tamoxifen(2006)51 cited
- → Quantitative real-time PCR analysis and microarray-based RNA expression of HER2 in relation to outcome(2007)40 cited
- → The Leukotriene Receptor CYSLT1 And 5- Lipoxygenase Are Upregulated In Colon Cancer(2003)36 cited